These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24101711)

  • 1. Association between serum cystatin C levels and coronary slow flow.
    Tasal A; Bacaksiz A; Ertas G; Vatankulu MA; Kul S; Sari S; Dãœz ME; Erdogan E; Sonmez O; Goktekin O
    Angiology; 2014 Oct; 65(9):831-7. PubMed ID: 24101711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of cystatin C with coronary artery disease and its severity.
    Doganer YC; Aydogan U; Aydogdu A; Aparci M; Akbulut H; Nerkiz P; Turker T; Cayci T; Barcin C; Saglam K
    Coron Artery Dis; 2013 Mar; 24(2):119-26. PubMed ID: 23211477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations of serum cystatin C and glomerular filtration rate with vascular lesions and severity in acute coronary syndrome.
    Zhang J; Wu X; Gao P; Yan P
    BMC Cardiovasc Disord; 2017 Jan; 17(1):47. PubMed ID: 28143410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating levels of β2-microglobulin and cystatin C are associated with left atrial size: additional link between the kidney and the heart.
    Liu YS; Wang X; Jiang WD; Huang ZW; Wang YM; Hao L; Xing JL; Wang L; Liu XX; Lounsbury P; Zhang M; Lu QH
    Clin Nephrol; 2013 Sep; 80(3):168-76. PubMed ID: 23849305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity of stable coronary artery disease and its biomarkers differ between men and women undergoing angiography.
    Gijsberts CM; Gohar A; Ellenbroek GH; Hoefer IE; de Kleijn DP; Asselbergs FW; Nathoe HM; Agostoni P; Rittersma SZ; Pasterkamp G; Appelman Y; den Ruijter HM
    Atherosclerosis; 2015 Jul; 241(1):234-40. PubMed ID: 25670231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystatin C-Adiponectin Complex in Plasma Associates with Coronary Plaque Instability.
    Matsumoto A; Yamamoto H; Matsuoka T; Kayama K; Onishi S; Matsuo N; Kihara S
    J Atheroscler Thromb; 2017 Sep; 24(9):970-979. PubMed ID: 28321013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystatin C and asymptomatic coronary artery disease in patients with metabolic syndrome and normal glomerular filtration rate.
    Qing X; Furong W; Yunxia L; Jian Z; Xuping W; Ling G
    Cardiovasc Diabetol; 2012 Sep; 11():108. PubMed ID: 22978689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association between cystatin C and different coronary atherosclerotic manifestations.
    Larsen TR; Gerke O; Diederichsen ACP; Lambrechtsen J; Steffensen FH; Sand NP; Antonsen S; Mickley H
    Scand J Clin Lab Invest; 2017 Dec; 77(8):574-581. PubMed ID: 28749732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of serum cystatin C in predicting coronary artery disease.
    Koc M; Batur MK; Karaarslan O; Abali G
    Cardiol J; 2010; 17(4):374-80. PubMed ID: 20690093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum cystatin C levels are associated with coronary artery disease and its severity.
    Wang GN; Sun K; Hu DL; Wu HH; Wang XZ; Zhang JS
    Clin Biochem; 2014 Nov; 47(16-17):176-81. PubMed ID: 25084128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cystatin C levels on angiographic atherosclerosis progression and events among postmenopausal women with angiographically decompensated coronary artery disease (from the Women's Angiographic Vitamin and Estrogen [WAVE] study).
    Patel D; Ahmad S; Silverman A; Lindsay J
    Am J Cardiol; 2013 Jun; 111(12):1681-7. PubMed ID: 23499273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the relationship between a narrow fragmented QRS complex and coronary slow flow.
    Cakmak HA; Aslan S; Gul M; Kalkan AK; Ozturk D; Celik O; Tasbulak O; Satilmisoglu MH
    Cardiol J; 2015; 22(4):428-36. PubMed ID: 25588536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocan may predict the presence of coronary slow flow and coronary artery disease.
    Efe MM; Akyüz A; Aydın C; Demirkıran A; Alpsoy Ş
    Rev Assoc Med Bras (1992); 2024; 70(8):e20240515. PubMed ID: 39230149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the lymphocyte-to-monocyte ratio, mean diameter of coronary arteries, and uric acid level with coronary slow flow in isolated coronary artery ectasia.
    Yang Z; Yuan J; Cui J; Guan H; Qiao S
    BMC Cardiovasc Disord; 2021 Mar; 21(1):156. PubMed ID: 33781230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Cystatin C Reflects Angiographic Coronary Collateralization in Stable Coronary Artery Disease Patients with Chronic Total Occlusion.
    Shen Y; Ding FH; Zhang RY; Zhang Q; Lu L; Shen WF
    PLoS One; 2015; 10(9):e0137253. PubMed ID: 26402227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography.
    Arbel Y; Finkelstein A; Halkin A; Birati EY; Revivo M; Zuzut M; Shevach A; Berliner S; Herz I; Keren G; Banai S
    Atherosclerosis; 2012 Dec; 225(2):456-60. PubMed ID: 23040448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of neutrophil gelatinase-associated lipocalin with the severity of coronary artery disease.
    Zografos T; Haliassos A; Korovesis S; Giazitzoglou E; Voridis E; Katritsis D
    Am J Cardiol; 2009 Oct; 104(7):917-20. PubMed ID: 19766756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The association between serum adiponectin levels and the severity of coronary artery lesions on the angiogram].
    Göksoy H; Dursunoğlu D; Oztürk M; Rota S
    Turk Kardiyol Dern Ars; 2009 Jun; 37(4):241-5. PubMed ID: 19717956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum neutrophil gelatinase-associated lipocalin and cystatin C are early biomarkers of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease.
    Alharazy SM; Kong N; Saidin R; Gafor AH; Maskon O; Mohd M; Zakaria SZ
    Angiology; 2014 May; 65(5):436-42. PubMed ID: 23580616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cytokine tumor necrosis factor-alpha and interleukin-6 associated with the severity of coronary artery disease: indicators of an active inflammatory burden?
    Gotsman I; Stabholz A; Planer D; Pugatsch T; Lapidus L; Novikov Y; Masrawa S; Soskolne A; Lotan C
    Isr Med Assoc J; 2008 Jul; 10(7):494-8. PubMed ID: 18751625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.